Table 4 This table depicts the reporting odds ratio (ROR) for the top 10 reported medications from 2010–2014
Medication | Reporting Odds Ratio (ROR) |
|---|---|
1. Zoledronic Acid | 263.1 |
2. Alendronate | 69.0 |
3. Denosumab | 37.2 |
4. Pamidronate | 294.8 |
5. Ibandronate | 34.9 |
6. Lenalidomide | 2.7 |
7. Risedronate | 48.6 |
8. Sunitinib | 5.9 |
9. Bevacizumab | 3.5 |
10. Prednisolone | 5.8 |